Sleek,
What I am immersing myself in this week is a podcast about CBDs. It goes back two or three years, so it will be interesting to see how the talks change since so much has happened within the last 3 years in the industry. From the outset, what I am finding from the discussions is a reliance for end-users to be able to receive the correct dosage in order to have positive effects. Additionally, the technique in which the dosage is administered can be the difference between success or failure since the acids in the stomach and intestines as well as the interactions within the liver can alter the intended dosage, if ingested. This is why the companies may come up with alternative ways to get the dosage into the body (under the tongue, or through the skin etc.
One interesting tidbit of information from a more recent podcast indicated that a European company testified in Congress recently about their ability to use CBDs in tampons. Imagine the possibilities there with pain management and with regard to limiting certain infections. I hope CANB is considering that as well.
But, that dosage concern will be vital information for doctors, patients, and government regulators, particularly when they want studies cited. This is where I see CANB in a great position. From what they were preaching in their shareholders' video it appears they are well in tune with dosage and getting the chemistry right. Whereas other companies may pump out products just to satisfy demand, CANB seems to be putting in their efforts early on to circumvent that inevitable 60 Minutes segment on the scam that is CBD dosage.
Forgive me if I err in any information on this site. I'm still learning the industry and the products.
Good luck to all
